New antibiotic match for tough UTIs?

NCT ID NCT03543436

Completed Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested if the antibiotic temocillin works as well as a stronger antibiotic (carbapenem) for treating urinary tract infections caused by resistant bacteria. 29 hospitalized adults took part. The goal was to see if both treatments could clear the infection and symptoms. The study was completed and results may help guide future treatment choices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTION DUE TO EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIACEAE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial urinary tract infection urinary tract infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

URINARY TRACT INFECTIONS

Contacts and locations

Locations

APHP - Beaujon Hospital

Paris, France
APHP - Cochin Hospital

Paris, 75014, France
APHP - Georges Pompidou European Hospital

Paris, France
APHP - Necker-Enfants maladies Hospital

Paris, 75015, France
APHP - Saint-Antoine Hospital

Paris, France
Bichat hospital

Paris, 75018, France
CHRU La Cavale Blanche

Brest, 29000, France
CHU Pontchaillou

Rennes, 35000, France
CHU de Grenoble Hospital

Grenoble, France
CHU de Martinique

Fort-de-france, Martinique, France
CHU de Pau

Pau, France
CHU de Poitiers

Poitiers, France
Groupe Hospitalier Diaconesses Croix Saint Simon

Paris, 75020, France
Melun Hospital - CHU Sud

Melun, 77, France
Saint-Joseph Hospital

Paris, France
Tenon Hospital

Paris, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.